Primary Care Consultation

Provide general health advice and promote specialized care to chronic and acute illness patients

Contact us to access this course

Course acquisition requires a coupon code.

SKU: MEDFAM Categories: , ,


Course type: Online; Self-Paced
Specialty: Family Medicine
Language: English / Portuguese
Resources: Debriefing Videos
Level: Intermediate / Advanced
Target: Medical
Modules: 5
Durations: 2 months
Time Effort: Up to 110 minutes per module
Certificate: Yes

Course Description

An essential element of any health care system is primary health care. Primary care consultations involve regular meetings and check-ups with a primary care physician using a comprehensive, longitudinal approach to the patient.

The primary care physician, as the name implies, is the patient’s first contact and provides general health advice and promotes specialized care in case of more serious illnesses and injuries. The scope of practice is broad and can act on a wide range of issues, including chronic or acute conditions, but also preventive care.

The Primary Care Consultation course includes cases in several areas, namely, endocrinology, nephrology, respiratory, allergology, and cardiology.

Course Overview

  • 5 Modules
    • 5 virtual patient cases of an intermediate level of complexity
  • Average Time to practice (per module)
    • Clinical Scenario: 20 minutes per attempt (3 attempts: 60 minutes)
    • Final attempt (if applicable): 20 minutes
    • Multiple Choice Question: 5 minutes
    • Feedback Area: 10 minutes
    • Learning Objectives and Scientific References: 5 minutes
    • Debriefing Video: 10 minutes
  • Online, Self-paced
    • You have up to 2 months to complete the 10 modules at your own pace. The course can be accessed through Body Interact at any time.
  • Certificate of Completion
    • After completing the course, you will receive a Certificate of Completion that can be added to your CV or Resume.

Learning Objectives

• Recognize early symptoms of serious illnesses
• Distinguish between self-limiting illnesses and problems that require further medical intervention
• Perform effective history taking, physical examination, and diagnosis based on current clinical evidence
• Communicate with a variety of patients identifying diagnoses and counselling to prevent illness
• Order tests and prescribes appropriate medical therapy

Clinical Competencies


• Universal safety measures procedures
• Promote patient safety
• Establish drug dosing for common medications
• Write prescriptions (including controlled drug)

Airway and Breathing

• Basic airway management
• Respiratory rate and rhythm assessment and interpretation
• Oximetry interpretation
• Basic spirometry (vital capacity, FEV 1 and interpretation)
• Thorax (shape, movement, diameter, ribs and diaphragm)
• Lung (percuss, fremitus, auscult and qualities of air sound, lobar locations) examination


• Assess and interpret pulse (rate, rhythm and volume) and blood pressure
• Detect heart murmurs and identify S1 (tricuspid, mitral) and S2 (pulmonary, aortic) heart sounds and detect S3, S4 gallops


• Assess mental status (level of arousal, response to auditory stimuli, to visual stimuli, noxious stimuli)
• Cranial nerves assessment
• Blood sugar measurement and interpretation


•Assess height and weight
• Lymph node assessment
• Cornea and anterior chamber assessment
• Gait and station and sensation assessment
• Skin test interpretation
• Motor function (voluntary movements, reflex withdraw, spontaneous, involuntary movements, tone)
• Interpretation of lab tests (Liver function, Renal function, Fluid/Electrolyte, Cardiac enzyme, Hematocrit, Arterial Blood Gas, coagulopathy rate interpretation, Lipid test, urinalysis, Thyroid test)
• Interpretation of imaging tests (Chest x-ray, Electrocardiogram interpretation, Ultrasonography, Nuclear imaging techniques, Computed tomography (CT) and Magnetic resonance imaging (MRI) result interpretation…)
• Abdominal examination (inspect, auscult, percuss and palp)
• Abdominal bruit
• Lens (clarity, artificial iol) and Disc (color, edges, size and shape) examination
• Ophthalmoscopic examination of fundi and retinae interpretation
• Nutrition management

Module 1 Unexplained weight loss

Context: The various symptoms presented by a patient may reveal clinical conditions that are critical. Early detection reduces morbidity and mortality by preventing or delaying possible complications. A greater understanding of the clinical conditions underlying the presenting symptoms can result in more patient-specific and tailored management.
Virtual Scenario: Mr. Townsend has been relatively healthy his whole life. However, recently he started to notice unexplained weight loss and is thirsty most of the time.

Module 2 Angina episode status

Context: The risk of progression or development of recurrent coronary artery disease after an acute episode is frequent and surveillance in the first few months is essential. Direct patient education is important and should be reinforced and documented.
Virtual Scenario: About a month ago, Adelaide required emergency medical care due to unstable angina. Today she has her first appointment for long-term health care management.

Module 3 Respiratory complaints

Context: Lung diseases can have diverse clinical presentations from multiple causes, including airflow limitation that may or not be reversible. Patients with these clinical conditions are at increased risk for developing comorbidities and their surveillance is critical.
Virtual Scenario: Mr. Bernard felt unwell a few months ago, and his health was not improving. He visited his General Practitioner, who referred him to a visit with Pulmonologist.

Module 4 Medical appointment for follow-up

Context: The presence of inherited conditions might be characterized by its recurrence. In this case, it has to be followed by a family medicine physician since the condition can be potentially fatal. The type, frequency, and severity of attacks vary between patients, and throughout the life of an individual.
Virtual Scenario: Anthony is being followed by an allergy/immunology outpatient clinic.

Module 5 Easily fatigue

Context: Fatigue is one of the most common complaints in medicine. Fatigue can be related to physical but also psychological symptoms. The anamnesis is very important to find out the meaning of the patient’s condition.
Virtual Scenario: Mr. Alexander has not been feeling well lately. In the past few months, his daily activities have been increasingly more difficult. Finally, his wife noticed he wasn’t well and persuaded him to visit his doctor.

Authors and Speakers

With a multidisciplinary group of international clinical reviewers, Body Interact ensures a high standard of accuracy, diversity, and impact of its course.

Intensive Care Expert Doctor Paulo Martins photo

Paulo Martins

Expert in Intensive Care
Faculty of Medicine, University of Coimbra, Portugal

Scientific References

  1.  Agusti A, Beasley R, Celli BR, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2020 Report). Global Initiative for Chronic Obstructive Lung Disease; 2020.
  2. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary SyndromesA Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139-e228.
  3. Bakris GL, Pitt B, Weir MR, et al. Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial. JAMA. 2015;314(2):151-161.
  4. Bushinsky DA, Williams GH, Pitt B, et al. Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia. Kidney Int. 2015;88(6):1427-1433.
  5. Craig T, Shapiro R, Vegh A, et al. Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema. Allergy Rhinol (Providence). 2017;8(1):e13-e19.
  6. Drawz PE, Babineau DC, Rahman M. Metabolic Complications are Common in Elderly Patients with Chronic Kidney Disease. J Am Geriatr Soc. 2012;60(2):310-315.
  7. Epstein M, Reaven NL, Funk SE, McGaughey KJ, Oestreicher N, Knispel J. Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors. Am J Manag Care. 2015;21(11 Suppl):S212-220.
  8. FDA approves new drug to treat hyperkalemia. Accessed April 13, 2017.
  9. Food & Drug Administration (FDA). FDA Drug Safety Communication: FDA requires drug interaction studies with potassium-lowering drug Kayexalate (sodium polystyrene sulfonate). Published October 22, 2015. Accessed April 13, 2017.
  10. Grundy Scott M., Stone Neil J., Bailey Alison L., et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 0(0):CIR.0000000000000625.
  11. Healthcare Cost and Utilization Project (HCUP). Accessed April 12, 2017.
  12. Kovesdy CP. Management of Hyperkalemia: An Update for the Internist. The American Journal of Medicine. 2015;128(12):1281-1287.
  13. Latts LM, Reaven NL, Funk SE, McGaughey KJ, Adamson RT. Hyperkalemia Is Highly Prevalent In Patients With Cardiorenal Comorbidities Compared To Patients Without These Comorbidities. Value in Health. 2015;18(3):A135.
  14. Lepage L, Dufour A-C, Doiron J, et al. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD. CJASN. November 2015:CJN.03640415.
  15. Otani IM, Christiansen SC, Busse P, et al. Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives. The Journal of Allergy and Clinical Immunology: In Practice. 2017;5(1):128-134.e4.
  16. Palmer BF, Clegg DJ. Hyperkalemia. JAMA. 2015;314(22):2405-2406.
  17. Reaven NL, Funk SE, Bakris GL. The economics of renoprotective therapy in advanced diabetic kidney disease. Am J Pharm Benefits. 2014;6(6):e169–e176.
  18. Relypsa Inc. Relypsa Submits Supplemental New Drug Application to FDA Requesting Label Changes for Veltassa Based on Phase 1 Drug-Drug Interaction Studies. GlobeNewswire News Room. Published May 25, 2016. Accessed April 13, 2017.
  19. Rydén L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal. 2013;34(39):3035-3087
  20. Sterns RH, Grieff M, Bernstein PL. Treatment of hyperkalemia: something old, something new. Kidney International. 2016;89(3):546-554.
  21. Veltassa [Package Insert]. Redwood City, CA: Relypsa, Inc; 2016.
  22. Wedzicha JA, Calverley PMA, Albert RK, et al. Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. European Respiratory Journal. 2017;50(3).
  23. Weir MR, Bakris GL, Bushinsky DA, et al. Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors. New England Journal of Medicine. 2015;372(3):211-221.
  24. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. January 2017:1-283.
  25. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104.
Brand Body Interact - Virtual patients

Body Interact This course is based on the most recent guidelines, using advanced medical simulation technology with virtual patients.


Explore more related courses by Body Interact

Start practicing with Body Interact



Log in

Access your account or create a free one at BI Store




Choose the online course your wish to practice with




Acquire it and receive the invoice on your email

4 Download



Download Body Interact app on App Store or Google Play